4//SEC Filing
Rogers Erica J. 4
Accession 0001593968-23-000796
CIK 0001397702other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:37 PM ET
Size
15.0 KB
Accession
0001593968-23-000796
Insider Transaction Report
Form 4
Rogers Erica J.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-05-11$1.60/sh+1,000$1,600→ 270,132 total - Exercise/Conversion
Common Stock
2023-05-11$1.60/sh+2,000$3,200→ 272,132 total - Sale
Common Stock
2023-05-11$35.51/sh−1,000$35,510→ 271,132 total - Sale
Common Stock
2023-05-11$35.51/sh−2,000$71,020→ 269,132 total - Exercise/Conversion
Option (right to buy)
2023-05-11−2,000→ 16,654 totalExercise: $1.60From: 2016-09-04Exp: 2026-08-04→ Common Stock (2,000 underlying) - Exercise/Conversion
Option (right to buy)
2023-05-11−1,000→ 15,654 totalExercise: $1.60From: 2016-09-04Exp: 2026-08-04→ Common Stock (1,000 underlying)
Holdings
- 83,843(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 8, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
- [F3]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001769940
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:37 PM ET
- Size
- 15.0 KB